0
0
Mumbai, September 2025 — A fresh controversy has erupted in Maharashtra’s healthcare sector as allopathic doctors strongly oppose the State Government’s recent directive enabling homeopathic practitioners who have completed a one-year Certificate Course in Modern Pharmacology (CCMP) to register with the Maharashtra Medical Council (MMC) and prescribe modern medicine independently. The Indian Medical Association (IMA) Maharashtra chapter has urged the government to immediately withdraw the order, citing risks to patient safety, legal concerns, and ongoing court proceedings that question the legitimacy of such registration.
Key Developments and Expert Concerns
The Maharashtra Medical Education and Drugs Department issued the order directing MMC to begin registration of CCMP-qualified homeopathic doctors on July 15, 2025, sparking intense debate. Estimates suggest between 10,000 to 90,000 homeopathic practitioners in Maharashtra could potentially register under this scheme. The CCMP course, initiated in 2014 under Maharashtra University of Health Sciences (MUHS), aims to train homeopaths in basic modern pharmacology to extend their scope in public healthcare, especially in underserved rural areas.
However, the IMA Maharashtra, led by State President Dr. Santosh Kadam, criticizes the move as “dangerous” and a “threat to public health,” stating that the CCMP program’s brief pharmacology training cannot substitute for rigorous 5.5 years of evidence-based medical education that MBBS doctors undergo. Dr. Kadam emphasizes that granting registration and prescribing rights to homeopaths undermines the standards of medical science and could compromise patient safety due to inadequate knowledge of diagnosis, treatment, and emergency care.
Dr. Kadam said, “MBBS doctors are comprehensively trained in modern medicine, surgery, and emergency care. In contrast, CCMP provides limited pharmacology knowledge over one year, insufficient for independent practice. Equating these qualifications could risk patient lives.” The IMA further argues that allowing homeopaths to prescribe modern medicine could cause misdiagnosis, adverse drug reactions, antibiotic resistance, and fatalities, especially in rural settings.
Ongoing Legal and Administrative Context
The controversy dates back to an amendment in 2014 to the Maharashtra Homoeopathic Practitioners Act and Medical Council Act, permitting homeopaths with CCMP certification to practice certain aspects of allopathy. However, this led to legal challenges from the IMA, culminating in a Bombay High Court stay on registration and practice rights pending final judgment. Despite this, the recent government directive appears to disregard the court’s position, prompting IMA to accuse the government of contempt of court and urge adherence to judicial propriety.
In response to protests and threats of a statewide strike by allopathic doctors, the government suspended the registration process in mid-2025 and constituted a seven-member committee including representatives from both medical councils, academia, and administration to assess the issue.
The Maharashtra State Advocate General has reportedly advised that maintaining a separate register for CCMP-qualified homeopaths under the MMC is legally permissible but does not confer any legal rights until the court delivers its final judgment. Yet, the government continues to push forward with registration plans.
Homeopathy Council and Supporters’ Perspective
Supporters, including the Maharashtra Homeopathy Council (MHC), hail the registration order as a recognition of the homeopathic practitioners’ expanded role in healthcare. The MHC administrator, Bahubali Shah, called the decision a “victory of truth,” averring that the one-year course equips homeopaths suitably for providing allopathic treatment where necessary, especially to alleviate specialist shortages in rural areas.
Practical and Public Health Implications
For the general public and health consumers, this policy could mean increased access to allopathic medicines through homeopathy practitioners trained via a short pharmacology course, potentially filling gaps in underserved areas. However, the quality, safety, and ethical implications of such practice remain hotly debated. If CCMP-qualified homeopaths prescribe outside their limited training scope or without proper diagnostic skills, it could lead to harmful outcomes.
Dr. Kadam warns of a “dilution of medical standards” and calls on patients to seek care only from fully qualified medical doctors. The risk of “mixopathy,” or blending distinct medical systems without solid evidence and regulation, may erode trust in healthcare and complicate patient care pathways.
The government plans to issue a Standard Operating Procedure detailing the extent of allopathic practice permitted for CCMP-qualified homeopaths, and disciplinary mechanisms similar to MBBS doctors’ medical negligence committees are to be instituted. Still, critics question the adequacy and enforcement of such measures given the fundamental discrepancies in training.
Balanced Perspective and Conclusion
While addressing healthcare gaps is vital, this initiative highlights the tension between expanding healthcare access and maintaining rigorous medical standards. Experts unaffiliated with the case emphasize that short-term pharmacology courses are insufficient to master allopathy’s complexities, which requires comprehensive education and clinical training.
Pending final judicial verdicts, the controversy underscores the necessity for clear, evidence-based policies respecting legal frameworks and patient safety. The Maharashtra case could set precedents affecting alternative medicine practitioners nationwide, stressing the importance of cautious, transparent reform in healthcare regulation.
Medical Disclaimer: This article is for informational purposes only and should not be considered medical advice. Always consult with qualified healthcare professionals before making any health-related decisions or changes to treatment plans. The information presented here is based on current research and expert opinions, which may evolve as new evidence emerges.
References:
